These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. The many varieties of catatonia. Fink M; Taylor MA Eur Arch Psychiatry Clin Neurosci; 2001; 251 Suppl 1():I8-13. PubMed ID: 11776271 [TBL] [Abstract][Full Text] [Related]
65. A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review. Chiou YJ; Lee Y; Lin CC; Huang TL Medicine (Baltimore); 2015 Oct; 94(43):e1752. PubMed ID: 26512569 [TBL] [Abstract][Full Text] [Related]
66. Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series. Ghaziuddin N; Hendriks M; Patel P; Wachtel LE; Dhossche DM J Child Adolesc Psychopharmacol; 2017 May; 27(4):359-365. PubMed ID: 28398818 [TBL] [Abstract][Full Text] [Related]
67. Neuroleptic malignant syndrome and its controversies. Margetić B; Aukst-Margetić B Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454 [TBL] [Abstract][Full Text] [Related]
68. [Neuroleptic malignant syndrome and related conditions]. Amore M; Montanari M Minerva Psichiatr; 1992; 33(4):259-83. PubMed ID: 1363674 [TBL] [Abstract][Full Text] [Related]
71. Neuroleptic malignant syndrome: a subtype of lethal catatonia? Ahuja N; Nehru R Acta Psychiatr Scand; 1990 Nov; 82(5):398. PubMed ID: 1980785 [No Abstract] [Full Text] [Related]
72. Diagnosis and treatment of neuroleptic malignant syndrome. Guerrero RM; Shifrar KA Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662 [TBL] [Abstract][Full Text] [Related]
73. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. Addonizio G; Susman VL J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837 [TBL] [Abstract][Full Text] [Related]
74. [Malignant neuroleptic syndrome: An atypical case in an adolescent affected by bipolar I disorder associated with catatonic syndrome]. Fernandez A; Pendaries G; Dor E; Askenazy F; Thümmler S Encephale; 2020 Apr; 46(2):153-154. PubMed ID: 31522832 [No Abstract] [Full Text] [Related]
75. Neuroleptic malignant syndrome and catatonia in a patient with dementia. Singh D; Forlano R; Athey R Aust N Z J Psychiatry; 2008 Jun; 42(6):547-8. PubMed ID: 18494081 [No Abstract] [Full Text] [Related]
76. Neuroleptic malignant syndrome and catatonia: one entity or two? Fink M Biol Psychiatry; 1996 Jan; 39(1):1-4. PubMed ID: 8719118 [No Abstract] [Full Text] [Related]
77. Catatonia, neuroleptics and brain damage--a case report. Chandran M; El-Shazly M J Psychopharmacol; 2009 Mar; 23(2):223-6. PubMed ID: 18562406 [TBL] [Abstract][Full Text] [Related]
78. Lethal catatonia responding to high-dose olanzapine therapy. Cassidy EM; O'Brien M; Osman MF; Finucane J; O'Keane V J Psychopharmacol; 2001 Dec; 15(4):302-4. PubMed ID: 11769826 [TBL] [Abstract][Full Text] [Related]
79. Lethal catatonia and neuroleptic malignant syndrome. Greedharry D; Bowen R Can J Psychiatry; 1993 Apr; 38(3):236-7. PubMed ID: 8098989 [No Abstract] [Full Text] [Related]
80. Neuroleptic malignant syndrome due to olanzapine. Hall KL; Taylor WH; Ware MR Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]